APA (7th ed.) Citation

LN, S., EY, F., W, R., X, Y., HK, E., & JM, B. (2023). The resurgence of the Adora2b receptor as an immunotherapeutic target in pancreatic cancer. Frontiers in immunology, 14, 1163585. https://doi.org/10.3389/fimmu.2023.1163585

Chicago Style (17th ed.) Citation

LN, Strickland, Faraoni EY, Ruan W, Yuan X, Eltzschig HK, and Bailey-Lundberg JM. "The Resurgence of the Adora2b Receptor as an Immunotherapeutic Target in Pancreatic Cancer." Frontiers in Immunology 14 (2023): 1163585. https://doi.org/10.3389/fimmu.2023.1163585.

MLA (9th ed.) Citation

LN, Strickland, et al. "The Resurgence of the Adora2b Receptor as an Immunotherapeutic Target in Pancreatic Cancer." Frontiers in Immunology, vol. 14, 2023, p. 1163585, https://doi.org/10.3389/fimmu.2023.1163585.